Topic

IgA Nephropathy

Speedway Scene reporting, analysis and commentary on IgA Nephropathy, pulled together from across our coverage.

1 article Last updated: 6 Jul 2026 1 section

Connected sections Health

Connected topics Vera Therapeutics Atacicept FDA Accelerated Approval Federal Reserve Donald Trump Iran

Lead story

Main entrance of the FDA campus in Silver Spring, Maryland. Photo: The U.S. Food and Drug Administration, Public domain, via Wikimedia Commons

Health

Vera's Atacicept Meets the FDA Clock as IgA Nephropathy Waits on a First-in-Class Verdict

A biotech racing toward its first commercial product collides with a regulator weighing whether reduced protein in urine is enough to clear a novel kidney drug. The July 7 answer will reshape both.

6 Jul 2026 ·6 min read

Read on

Keep following this story

Everything Speedway Scene has published on IgA Nephropathy, gathered in one place: the reporting, the analysis and the commentary that track the subject.

Connected topics

Vera Therapeutics Atacicept FDA Accelerated Approval Federal Reserve Donald Trump Iran Array Ukraine Kevin Warsh CDC

Connected sections